The best defence against Covid19 is a strong immune system...
It is well established that the death rate from the coronavirus is highest amongst the already sick, weak and elderly. In other words those with an already compromised immune system. So although there is no known current cure there certainly is a defence... strengthen your own immune system! Click here to learn more.
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Vol. 288, Issue 2, 679-684, February 1999
Finasteride, a 5 -Reductase Inhibitor, Blocks the Anticonvulsant Activity of Progesterone in Mice
J Am Coll Cardiol, 2000; 36:2154-2159
Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise- induced myocardial ischemia in postmenopausal women.
Obstetrics & Gynecology 2000;95:403-406
Direct Transport of Progesterone From Vagina to Uterus
Acta Obstet Gynecol Scand 2001; 80: 972-973
Substantial relief of myopathic disability by progesterone therapy. Myopathy delineates all disorders affecting the human musculature. Myopathies are known to be associated with endocrinological disorders like hypo- and hyperthyroidism, hypo- and hyperparathyroidism and glucocorticoid excess (1). To this date there exists no information of an association between luteal insufficiency and myopathic disorders. We describe here the progesterone treatment of a patient with a most likely congenital myopathy and we show that interdisciplinary cooperation can be fruitful.
(Original in pdf format)
American Journal of Obstetrics and Gynecology
Volume 188, Issue 2 , February 2003, Pages 419-424
Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study.
Exp Clin Endocrinol Diabetes 2003; 111: 267-273
One Year Follow-Up of Hormone Replacement Therapy with Percutaneous Estradiol and Low-Dose Vaginal Natural Progesterone in Women with Mild to Moderate Hypertension
Akush Ginekol (Sofiia). 2004;43(5):22-4.
Utrogestan and high risk pregnancy